dapivirine vaginal ring
Dapivirine vaginal ring: increasing SA’s HIV arsenal
The dapivirine vaginal ring will soon be available to women and young girls at limited pilot sites from June. The South African Health Products Regulatory Authority (SAHPRA) approved its use by women ages 18 and older to reduce their…
Dapivirine vaginal ring: SA rollout put on ice for now
South African women will have to wait before laying their hands on the newly-approved dapivirine vaginal ring (DPV-VR – while the National Department of Health assesses the effectiveness of the HIV prevention device. Department of Health (DOH) spokesperson, Foster Mohale,…
HIV prevention: Vaginal ring gives hope to African women
Studies show that the dapivirine vaginal ring offers new hope as an additional HIV prevention option for young women in Africa, lowering the health risk factors associated with HIV infections.
Read More » HIV prevention: Vaginal ring gives hope to African women
New long-acting injectable drug might soon be a key HIV treatment
American scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection with fewer side effects and could eventually replace drug ‘cocktail’ therapies.
Read More » New long-acting injectable drug might soon be a key HIV treatment